- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
Patent holdings for IPC class C07K 16/26
Total number of patents in this class: 932
10-year publication summary
82
|
82
|
69
|
94
|
71
|
72
|
63
|
62
|
57
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
H. Lundbeck A/S | 1249 |
47 |
Adrenomed AG | 43 |
27 |
Eli Lilly and Company | 3720 |
21 |
Progastrine et Cancers S.A R.L. | 27 |
20 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2617 |
19 |
Teva Pharmaceuticals International GmbH | 382 |
19 |
Amgen Inc. | 3899 |
18 |
Regeneron Pharmaceuticals, Inc. | 3986 |
17 |
Centre National de La Recherche Scientifique | 10102 |
15 |
F. Hoffmann-La Roche AG | 7942 |
12 |
Merus N.V. | 216 |
12 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
11 |
Intrinsic Lifesciences LLC | 18 |
10 |
Les Laboratoires Servier | 597 |
10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
10 |
Roche Diagnostics Operations, Inc. | 1434 |
9 |
B.r.a.h.m.s GmbH | 174 |
9 |
Board of Regents, The University of Texas System | 5619 |
8 |
AlderBio Holdings LLC | 22 |
8 |
Sysmex Corporation | 1428 |
8 |
Other owners | 622 |